Bloodstream infection by Vancomycin-resistant enterococci A49.13 U80.30
Conditions
Interventions
Group 1: Patients with a bloodstream infection caused by vancomycin-resistant enterococci (VRE) are followed-up for 30 days regarding hospital mortality and the course of the bloodstream infection.
Sponsors
Universitätsklinikum Würzburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Blood culture-confirmed VRE-bloodstream infection
Exclusion criteria
Exclusion criteria: No clinical symptoms of bloodstream infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intrahospital mortality within 30 days after diagnosis. Data are collected via routine clinical documentation or, if necessary, through surveys (by telephone or mail) or inquiries to population registries. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prolonged bloodstream infection (>72 hours). Time interval from admission to the onset of the bloodstream infection. Data are collected via routine clinical documentation at the time of diagnosis, 3–5 days after diagnosis, and 30 days after diagnosis. | — |
Countries
Germany
Contacts
Public ContactKathrin Ungethüm
Universitätsklinikum Würzburg
Outcome results
None listed